SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 77.61+3.5%Nov 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (929)5/23/2005 8:44:32 PM
From: Jibacoa  Read Replies (1) of 3722
 
Another stock that had a slight spike last week (up 25% from the low of 3.13 on May 17)was NGEN, which had a smaller loss for 2004 ($1.09 vs. $1.23 in 2003) and also the EL for 2005 is about half of the loss in 2004 ($0.58 vs. $1.09) & for 2006 the EL is $0.33/share.

The stock was down 4.62% today, but it was up slightly AHs.<g>

NGEN seems to have support at the 3.35 to 3.40 level and nearest resistance at 3.95

It reportedly has around $0.80 in cash/share and its Debt/Eq. ratio is around 0.01 The BV reportedly is around $3

It had some patents approved earlier this month and looking at its long term chart, the R/R ratio doesn't look bad.<g>

In the 1st Q the loss was smaller ($0.17 vs. $0.20/share) and revenues were up 47%

Last year it acquired SynX Pharma and Epoch Biosciences.

bigcharts.marketwatch.com

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext